Market Overview:
The global tuberculosis prevention and treatment vaccine market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The increasing incidence of tuberculosis, rising awareness about the benefits of vaccination, and technological advancements are some of the major factors that are expected to drive the growth of this market during the forecast period. By type, catheter ablation is expected to be the fastest-growing segment in this market during the forecast period. By application, hospitals are expected to be the largest segment in this market duringthe forecast period.
Product Definition:
A tuberculosis vaccine is a vaccine that is used to prevent tuberculosis. The importance of tuberculosis prevention and treatment vaccine is that it can help prevent the spread of tuberculosis and also help treat people who have been infected with the disease.
Catheter Ablation:
The global Catheter Ablation market size was valued at USD 1.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of chronic conditions, such as cardiovascular diseases, urological disorders & urinary blockage, neurological disorders & peripheral vascular disease and respiratory diseases is one of the key factors anticipated to boost growth during the forecast period.
Maze Surgery:
Maze surgery is a new surgical technique that involves the use of computer assisted navigation tools to direct the path of surgical instruments. The purpose of this surgery is to create a map or series of paths through which the surgeons and medical staff can navigate easily during complicated surgeries. This helps in minimizing errors and provides better patient outcomes at reduced costs.
The global tuberculosis prevention.
Application Insights:
The other application segment includes TB clinics, home care, and others. The hospital segment dominated the market in 2017 due to factors such as increasing prevalence of tuberculosis and government initiatives that support the adoption of preventive measures for TB. According to WHO, in 2016 approximately 10 million people were diagnosed with active tuberculosis worldwide while 1.3 million died due to the disease. In addition, according to estimates by UITAT (the United Nations International Drug Control Programme), around USD 12 billion is spent annually on drug abuse across the globe which also contributes towards a significant revenue share held by this segment.
Hospitals are considered as one of the most effective settings for delivering preventive services owing to several advantages such as large patient population within a short distance from an area; easy access for providing treatment; presence of highly skilled healthcare professionals who can provide better diagnosis resulting in early treatment initiation; availability of diagnostic facilities including laboratories.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing prevalence of tuberculosis and growing target population. According to WHO, around 9,000 new cases of MDR-TB were reported in 2016; whereas, CDC stated that 1,638 cases were registered in 2015. Furthermore, increasing number of FDA approved vaccine products and rising awareness about preventive measures are also contributing towards market growth.
Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period due to high incidence rate of TB coupled with large target population pooling across various countries such as India & China & Indonesia etc.; hence resulting into a greater demand for prophylaxis vaccines against this disease which poses a huge public health concern globally.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe: The global incidence of tuberculosis is increasing at an alarming rate. According to the World Health Organization (WHO), there were 10.4 million new cases of TB and 1.8 million deaths due to TB in 2016. This number is expected to increase in the coming years, owing to the increasing population and changing lifestyle habits. This will create a high demand for TB prevention and treatment vaccines, which can help reduce the incidence of this deadly disease.
- Growing awareness about tuberculosis: There is a growing awareness among people about tuberculosis and its prevention methods, such as vaccination against TB infection. This is helping to drive demand for TB prevention and treatment vaccines worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tuberculosis Prevention and Treatment Vaccine Market Research Report
By Type
Catheter Ablation, Maze Surgery
By Application
Hospitals, Ambulatory Surgical Centers, Other
By Companies
Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Tuberculosis Prevention and Treatment Vaccine Market Report Segments:
The global Tuberculosis Prevention and Treatment Vaccine market is segmented on the basis of:
Types
Catheter Ablation, Maze Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Abbott
- Medtronic
- Japan Lifeline
- Boston Scientific
- Atricure
- Biotroik
- OSYPKA AG
- Cardiofocus
- MicroPort EP MedTech
- Synaptic Medical
Highlights of The Tuberculosis Prevention and Treatment Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Catheter Ablation
- Maze Surgery
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tuberculosis Prevention and Treatment Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The tuberculosis prevention and treatment vaccine is a vaccine that helps prevent tuberculosis. It is given to people who are at risk of getting tuberculosis, such as people who have HIV or AIDS, cancer patients, and those who have received radiation therapy to the chest.
Some of the major players in the tuberculosis prevention and treatment vaccine market are Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical.
The tuberculosis prevention and treatment vaccine market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tuberculosis Prevention and Treatment Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tuberculosis Prevention and Treatment Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tuberculosis Prevention and Treatment Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tuberculosis Prevention and Treatment Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tuberculosis Prevention and Treatment Vaccine Market Size & Forecast, 2020-2028
4.5.1 Tuberculosis Prevention and Treatment Vaccine Market Size and Y-o-Y Growth
4.5.2 Tuberculosis Prevention and Treatment Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Catheter Ablation
5.2.2 Maze Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tuberculosis Prevention and Treatment Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Catheter Ablation
9.6.2 Maze Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Catheter Ablation
10.6.2 Maze Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Catheter Ablation
11.6.2 Maze Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Catheter Ablation
12.6.2 Maze Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Catheter Ablation
13.6.2 Maze Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tuberculosis Prevention and Treatment Vaccine Market: Competitive Dashboard
14.2 Global Tuberculosis Prevention and Treatment Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Abbott
14.3.3 Medtronic
14.3.4 Japan Lifeline
14.3.5 Boston Scientific
14.3.6 Atricure
14.3.7 Biotroik
14.3.8 OSYPKA AG
14.3.9 Cardiofocus
14.3.10 MicroPort EP MedTech
14.3.11 Synaptic Medical
